Jacobs Levy Equity Management, Inc United Therapeutics Corp Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

A detailed history of Jacobs Levy Equity Management, Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 2,268 shares of UTHR stock, worth $827,751. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,268

Previous 2,268 -0.0%

Holding current value

$827,751

Previous $722,000 12.47%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$210.76 - $249.51 $15.2 Million - $18 Million	-72,203 Reduced 96.95%	2,268 $521,000
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $25.4 Million - $30.4 Million	-118,205 Reduced 61.35%	74,471 $16.4 Million
Q3 2023 Nov 16, 2023	SELL	$211.82 - $248.24 $6.75 Million - $7.91 Million	-31,881 Reduced 14.2%	192,676 $43.5 Million
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $6.72 Million - $7.63 Million	-32,733 Reduced 12.72%	224,557 $49.6 Million
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $13.2 Million - $17.1 Million	-61,753 Reduced 19.36%	257,290 $57.6 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $9.59 Million - $13.1 Million	-46,576 Reduced 12.74%	319,043 $88.7 Million
Q3 2022 Nov 15, 2022	BUY	$203.3 - $244.17 $7 Million - $8.4 Million	34,412 Added 10.39%	365,619 $76.6 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $2.51 Million - $3.46 Million	-14,369 Reduced 4.16%	331,207 $78 Million
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $6.68 Million - $8.6 Million	-40,173 Reduced 10.41%	345,576 $62 Million
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $18.8 Million - $22.1 Million	-102,263 Reduced 20.96%	385,749 $83.4 Million
Q3 2021 Nov 15, 2021	SELL	$179.86 - $214.88 $512,061 - $611,763	-2,847 Reduced 0.58%	488,012 $90.1 Million
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $2.39 Million - $2.97 Million	-14,036 Reduced 2.78%	490,859 $88.1 Million
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $302,030 - $343,055	1,962 Added 0.39%	504,895 $84.5 Million
Q4 2020 Feb 16, 2021	SELL	$101.87 - $151.79 $2.61 Million - $3.89 Million	-25,633 Reduced 4.85%	502,933 $76.3 Million
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $7.72 Million - $9.36 Million	77,308 Added 17.13%	528,566 $53.4 Million
Q2 2020 Aug 17, 2020	BUY	$92.74 - $125.82 $8.04 Million - $10.9 Million	86,678 Added 23.77%	451,258 $54.6 Million
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $22.1 Million - $32.1 Million	277,867 Added 320.44%	364,580 $34.6 Million
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $6.13 Million - $7.46 Million	78,253 Added 924.98%	86,713 $7.64 Million
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $633,231 - $727,475	8,460 New	8,460 $675,000

Others Institutions Holding UTHR

# of Institutions

673

Shares Held

42.2M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc United Therapeutics Corp Transaction History